Paper36780326
Virus Inactivation Based on Optimal Surfactant Reservoir of Mesoporous Silica.
Hirao R and 3 others. ACS Appl Bio Mater, 2023. Cited by 3 papers, by iCite.
Cite this record
ConductScience Library. Virus Inactivation Based on Optimal Surfactant Reservoir of Mesoporous Silica. Papers, record 36780326. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36780326
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics7
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Surface-Active Agents | Major topic |
| COVID-19 | Major topic |
| Humans | |
| Virus Inactivation | |
| SARS-CoV-2 | |
| Cetrimonium | |
| Micelles |
Source PubMed
References39
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 28797969 | Bioactive mesoporous silica nanostructures with anti-microbial and anti-biofilm properties. | Int J Pharm | 2017 | https://conductscience.org/library/papers/28797969 | PubMed |
| 2 | 37566314 | Increased Use of Quaternary Ammonium Compounds during the SARS-CoV-2 Pandemic and Beyond: Consideration of Environmental Implications. | Environ Sci Technol Lett | 2020 | https://conductscience.org/library/papers/37566314 | PubMed |
| 3 | 33034443 | Antimicrobial Nanomaterials and Coatings: Current Mechanisms and Future Perspectives to Control the Spread of Viruses Including SARS-CoV-2. | ACS Nano | 2020 | https://conductscience.org/library/papers/33034443 | PubMed |
| 4 | 30300551 | Encapsulation and Release of Essential Oils in Functional Silica Nanocontainers. | Langmuir | 2018 | https://conductscience.org/library/papers/30300551 | PubMed |
| 5 | 25050635 | Facile, one-pot synthesis, and antibacterial activity of mesoporous silica nanoparticles decorated with well-dispersed silver nanoparticles. | ACS Appl Mater Interfaces | 2014 | https://conductscience.org/library/papers/25050635 | PubMed |
| 6 | 34149298 | The viability of SARS-CoV-2 on solid surfaces. | Curr Opin Colloid Interface Sci | 2021 | https://conductscience.org/library/papers/34149298 | PubMed |
| 7 | 34880490 | The emergence, genomic diversity and global spread of SARS-CoV-2. | Nature | 2021 | https://conductscience.org/library/papers/34880490 | PubMed |
| 8 | 25319365 | Antibacterial dental composites with chlorhexidine and mesoporous silica. | J Dent Res | 2014 | https://conductscience.org/library/papers/25319365 | PubMed |
| 9 | 35500100 | Self-Healing and Antibacterial Essential Oil-Loaded Mesoporous Silica/Polyacrylate Hybrid Hydrogel for High-Performance Wearable Body-Strain Sensing. | ACS Appl Mater Interfaces | 2022 | https://conductscience.org/library/papers/35500100 | PubMed |
| 10 | 9880479 | Antiseptics and disinfectants: activity, action, and resistance. | Clin Microbiol Rev | 1999 | https://conductscience.org/library/papers/9880479 | PubMed |
| 11 | 24131516 | Vancomycin-modified mesoporous silica nanoparticles for selective recognition and killing of pathogenic gram-positive bacteria over macrophage-like cells. | ACS Appl Mater Interfaces | 2013 | https://conductscience.org/library/papers/24131516 | PubMed |
| 12 | 25655182 | Bifunctionalized mesoporous silica-supported gold nanoparticles: intrinsic oxidase and peroxidase catalytic activities for antibacterial applications. | Adv Mater | 2015 | https://conductscience.org/library/papers/25655182 | PubMed |
| 13 | 23526816 | Enzyme-coated mesoporous silica nanoparticles as efficient antibacterial agents in vivo. | Adv Healthc Mater | 2013 | https://conductscience.org/library/papers/23526816 | PubMed |
| 14 | 34067553 | Antiviral Activity of Silver, Copper Oxide and Zinc Oxide Nanoparticle Coatings against SARS-CoV-2. | Nanomaterials (Basel) | 2021 | https://conductscience.org/library/papers/34067553 | PubMed |
| 15 | 29208293 | Mesoporous silica-based bioactive glasses for antibiotic-free antibacterial applications. | Mater Sci Eng C Mater Biol Appl | 2018 | https://conductscience.org/library/papers/29208293 | PubMed |
| 16 | 32657566 | A Surface Coating that Rapidly Inactivates SARS-CoV-2. | ACS Appl Mater Interfaces | 2020 | https://conductscience.org/library/papers/32657566 | PubMed |
| 17 | 33350025 | The unique features of SARS-CoV-2 transmission: Comparison with SARS-CoV, MERS-CoV and 2009 H1N1 pandemic influenza virus. | Rev Med Virol | 2021 | https://conductscience.org/library/papers/33350025 | PubMed |
| 18 | 35138100 | Transparent Anti-SARS-CoV-2 and Antibacterial Silver Oxide Coatings. | ACS Appl Mater Interfaces | 2022 | https://conductscience.org/library/papers/35138100 | PubMed |
| 19 | 32412231 | Are Quaternary Ammonium Compounds, the Workhorse Disinfectants, Effective against Severe Acute Respiratory Syndrome-Coronavirus-2? | ACS Infect Dis | 2020 | https://conductscience.org/library/papers/32412231 | PubMed |
| 20 | 28285049 | Adsorption and release of ampicillin antibiotic from ordered mesoporous silica. | J Colloid Interface Sci | 2017 | https://conductscience.org/library/papers/28285049 | PubMed |
Cited by2
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 3 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 38343039 | Polypropylene-Rendered Antiviral by Three-Dimensionally Surface-Grafted Poly(N-benzyl-4-vinylpyridinium bromide). | ACS Appl Mater Interfaces | 2024 | https://conductscience.org/library/papers/38343039 | PubMed |
| 38140133 | A Novel Handrub Tablet Loaded with Pre- and Post-Biotic Solid Lipid Nanoparticles Combining Virucidal Activity and Maintenance of the Skin Barrier and Microbiome. | Pharmaceutics | 2023 | https://conductscience.org/library/papers/38140133 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36780326
GET https://conductscience.org/api/papers/v1/36780326/references?page=2